Applegate went public with her multiple sclerosis diagnosis in 2021. She now co-hosts a podcast about life with MS, called “MeSsy,” alongside actor Jamie-Lynn Sigler. Sigler, best known for her role ...

Christina Applegate got emotional opening up about her struggle with multiple sclerosis, nearly four years after she was first diagnosed. “I am defined by it right now,” the actor said during ...

Results from the HERCULES phase 3 study showed delay in disability progression in people living with non-relapsing secondary progressive multiple sclerosis Tolebrutinib has the potential to be the ...

Results from the HERCULES phase 3 study showed delay in disability progression in people living with non-relapsing secondary progressive multiple sclerosis Tolebrutinib has the potential to be the ...

Throughout the course of multiple sclerosis, gradually progressive neurologic impairment can occur, which has been called disability accrual. Current disease-modifying therapies for multiple ...

A new study published in Multiple Sclerosis and Related Disorders highlights the potential of "More Stamina," a gamified mobile health (mHealth) app designed to help people with multiple sclerosis ...

While topline results of HERCULES were first presented at the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) meeting last September, the peer-reviewed paper offers ...

Researchers at University College London (UCL) have developed an innovative artificial intelligence (AI) tool called MindGlide, designed to transform the way multiple sclerosis (MS) treatments are ...

More information: Repurposing Clinical MRI Archives for Multiple Sclerosis Research with a Flexible, Single-Contrast Approach: New Insights from Old Scans, Nature Communications (2025). DOI: 10. ...

However, finding the connection was not easy. “It started with the observation that the epidemiology of multiple sclerosis is quite unique because there is a very striking geographical ...

A new artificial intelligence (AI) tool that can help interpret and assess how well treatments are working for patients with multiple sclerosis (MS) has been developed by UCL researchers.